GO:0003208 cardiac ventricle morphogenesis: Chamber Formation, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0003208 cardiac ventricle morphogenesis describes the biological process by which the cardiac ventricle is generated and organized, receiving blood from the atrium and pumping it out of the heart.
• Ventricular morphogenesis requires coordinated regulation of transcription factors such as Hey2, Tbx2, Mycn, and Gata4, which pattern the right and left ventricles.
• Distinct cellular mechanisms govern ventricular versus atrial chamber wall formation, including differences in cardiomyocyte proliferation and trabeculation.
• Spatially organized cellular communities, including cardiomyocytes, fibroblasts, and endothelial cells, form the developing human heart ventricle.
• Disruption of ventricular morphogenesis is linked to congenital heart defects and impaired myocardial repair, making it a key area for disease modeling.
• CRISPR-based knockout, knock-in, and overexpression models enable causal testing of genes involved in cardiac ventricle morphogenesis.
Description
Cardiac ventricle morphogenesis (GO:0003208) is the developmental process that builds the ventricular chambers of the heart, ensuring they can receive blood from the atria and pump it to the lungs and body. This process is fundamental to heart function, and its disruption leads to congenital heart defects, the most common birth defects in humans. Understanding the molecular and cellular mechanisms of ventricular morphogenesis is therefore critical for developmental biology and regenerative medicine. Recent single-cell and spatial transcriptomics studies have revealed that the developing human heart ventricle is composed of spatially organized cellular communities that coordinate morphogenesis. Animal models, particularly zebrafish and mouse, have provided insights into the transcription factor networks and signaling pathways that control ventricular chamber formation and growth. This article synthesizes current knowledge on the definition, mechanisms, key genes, and research methods for studying cardiac ventricle morphogenesis, with a focus on how CRISPR-based models can accelerate discovery.
cardiac ventricle morphogenesis At A Glance
| GO ID | GO:0003208 |
|---|---|
| GO term | cardiac ventricle morphogenesis |
| Ontology | biological_process |
| Synonym | none |
| Major function | Generation and organization of the cardiac ventricle, enabling blood reception from the atrium and pumping out of the heart |
| Related process | Cardiac chamber development, heart morphogenesis |
| Taxonomic range | Metazoa, particularly vertebrates |
| Key cellular events | Cardiomyocyte proliferation, differentiation, trabeculation, and chamber wall formation |
What Is GO:0003208?
According to the Gene Ontology, GO:0003208 cardiac ventricle morphogenesis is defined as the process in which the cardiac ventricle is generated and organized. A cardiac ventricle receives blood from a cardiac atrium and pumps it out of the heart. This encompasses the coordinated cellular behaviors, differentiation events, and tissue remodeling steps that shape the ventricular chamber during embryogenesis.
Why Is cardiac ventricle morphogenesis Important in Cell Biology?
Cardiac ventricle morphogenesis is essential for establishing a functional heart, and defects in this process cause congenital heart diseases such as ventricular septal defects and hypoplastic left heart syndrome. Understanding the genetic and cellular control of ventricular morphogenesis can inform strategies for myocardial repair and regeneration, as injury-responsive programs in the ventricle may be reactivated for therapeutic benefit.
• Congenital heart defects affecting the ventricle are among the most common birth anomalies, often arising from disrupted morphogenesis.
• Ventricular morphogenesis determines the number and organization of cardiomyocytes, directly impacting contractile function.
• The transcription factor network involving Hey2, Tbx2, and Mycn controls right ventricle development, and its perturbation leads to chamber-specific defects.
• Injury-responsive programs, such as Gata4 activation, shape the zebrafish cardiac ventricle and may inform regenerative medicine.
• Spatially organized cellular communities in the human fetal heart provide a blueprint for understanding ventricular development.
• Angiogenesis from pre-existing coronary vessels via DLL4-NOTCH1 signaling supports ventricular growth and repair.
• Enhancing myocardial repair with engineered CardioClusters demonstrates the therapeutic potential of targeting ventricular cell communities.
• Zebrafish models enable automated cardiac rhythm measurement, facilitating functional studies of ventricular morphogenesis mutants.
• Outflow tract sculpting is tightly linked to ventricular morphogenesis, and its failure contributes to conotruncal defects.
What Happens During cardiac ventricle morphogenesis?
Specification of the ventricular field
In simple terms: Early in development, a group of cells is told to become the future ventricle.
The ventricular field is specified by a combination of signaling molecules and transcription factors. In zebrafish and mouse, the transcription factor Hey2 plays a role in right ventricle development by regulating the Tbx2-Mycn pathway during cardiac morphogenesis. This specification step establishes the boundaries between the future ventricle and atrium, ensuring proper chamber identity.
Cardiomyocyte proliferation and chamber wall formation
In simple terms: Heart muscle cells multiply to build the thick walls of the ventricle.
Distinct mechanisms regulate ventricular and atrial chamber wall formation, with differences in cardiomyocyte proliferation and differentiation. The ventricular wall thickens through coordinated proliferation and hypertrophy of cardiomyocytes, a process that is essential for generating the contractile force needed for pumping blood. Disruption of this step leads to thin-walled ventricles and heart failure.
Trabeculation and compaction
In simple terms: The inner surface of the ventricle forms ridges that later compact into solid muscle.
Trabeculation increases the surface area of the ventricular lumen for nutrient exchange before coronary circulation is established. Subsequently, compaction remodels the trabeculae into a solid ventricular wall. This process is regulated by signaling pathways including Notch, which also controls perinatal angiogenesis from pre-existing coronary vessels via DLL4-NOTCH1 signaling. Proper trabeculation and compaction are critical for ventricular function.
Formation of the outflow tract and ventricular-arterial connection
In simple terms: The exit path from the ventricle is sculpted to connect to the arteries.
Sculpting the cardiac outflow tract is an integral part of ventricular morphogenesis, ensuring that blood pumped from the ventricle enters the correct vessels. This involves remodeling of the endocardial cushions and alignment of the outflow tract with the ventricular chambers. Defects in this step cause conotruncal anomalies such as tetralogy of Fallot.
Cellular community organization and spatial patterning
In simple terms: Different cell types arrange themselves in specific patterns to form the ventricle.
Spatially organized cellular communities form the developing human heart, with distinct zones of cardiomyocytes, fibroblasts, and endothelial cells. This spatial organization is essential for coordinated ventricular morphogenesis and function. Single-cell and spatial transcriptomics have revealed that these communities communicate via signaling pathways to direct ventricular growth and remodeling.
Key Genes Involved in GO:0003208 cardiac ventricle morphogenesis
The following genes and proteins have been experimentally implicated in cardiac ventricle morphogenesis, based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| Hey2 | Transcription factor regulating right ventricle development via Tbx2-Mycn pathway | Knockout in zebrafish causes right ventricle defects |
| Tbx2 | Transcription factor downstream of Hey2, controls chamber identity | Part of the Hey2-Tbx2-Mycn axis in ventricular morphogenesis |
| Mycn | Transcription factor promoting cardiomyocyte proliferation | Regulated by Hey2-Tbx2 during right ventricle development |
| Gata4 | Injury-responsive transcription factor shaping the ventricle | Zebrafish gata4 program is activated upon injury |
| Dll4 | Notch ligand involved in angiogenesis | Regulates perinatal angiogenesis from pre-existing coronary vessels |
| Notch1 | Receptor for DLL4, controls angiogenesis and trabeculation | DLL4-NOTCH1 signaling in coronary vessel development |
| Nkx2-5 | Early cardiac transcription factor | Not directly cited in provided references, but commonly studied in ventricular morphogenesis |
| Hand2 | Transcription factor for ventricular expansion | Not directly cited in provided references |
| Mef2c | Transcription factor for cardiomyocyte differentiation | Not directly cited in provided references |
| Tbx5 | Transcription factor for chamber specification | Not directly cited in provided references |
| Pitx2 | Left-right asymmetry determinant | Not directly cited in provided references |
| Sox9 | Endocardial cushion formation | Not directly cited in provided references |
| Vegfa | Angiogenesis and ventricular growth | Not directly cited in provided references |
| Fgf8 | Outflow tract and ventricular morphogenesis | Not directly cited in provided references |
| Bmp4 | Trabeculation and cushion formation | Not directly cited in provided references |
| Wnt | Signaling in cardiac progenitors | Not directly cited in provided references |
| Nrg1 | ErbB signaling in trabeculation | Not directly cited in provided references |
| EphrinB2 | Ventricular trabeculation and angiogenesis | Not directly cited in provided references |
How Is cardiac ventricle morphogenesis Regulated?
Cardiac ventricle morphogenesis is regulated by a combination of transcription factor networks and signaling pathways. The Hey2-Tbx2-Mycn pathway controls right ventricle development, with Hey2 acting upstream of Tbx2 and Mycn. Notch signaling, via DLL4-NOTCH1, regulates angiogenesis and potentially trabeculation during ventricular growth. Additionally, injury-responsive programs such as Gata4 activation can reshape the ventricle, indicating that morphogenetic processes can be reactivated in adulthood. Distinct regulatory mechanisms govern ventricular versus atrial wall formation, highlighting chamber-specific control.
cardiac ventricle morphogenesis and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| Hey2 | Right ventricle hypoplasia, congenital heart defects | Zebrafish knockout |
| Gata4 | Myocardial injury response, heart failure | Zebrafish injury model |
| Dll4 | Coronary artery anomalies, impaired angiogenesis | Mouse knockout |
| Notch1 | Ventricular trabeculation defects | Mouse conditional knockout |
| Mycn | Ventricular cardiomyocyte proliferation defects | Zebrafish knockdown |
Congenital heart defects
Disruption of cardiac ventricle morphogenesis leads to congenital heart defects, including ventricular septal defects, hypoplastic left heart syndrome, and tetralogy of Fallot. Abnormal outflow tract sculpting is a major contributor to conotruncal anomalies. Mutations in genes such as Hey2, Tbx2, and Mycn have been linked to chamber-specific defects in animal models.
Myocardial infarction and heart failure
Impaired ventricular morphogenesis or regeneration contributes to heart failure after myocardial infarction. Enhancing myocardial repair with CardioClusters, which mimic developmental cell communities, has been proposed as a therapeutic strategy. Understanding developmental pathways may unlock regenerative approaches.
Coronary artery disease
Perinatal angiogenesis from pre-existing coronary vessels via DLL4-NOTCH1 signaling is critical for ventricular growth and repair. Defects in this pathway can lead to coronary artery abnormalities and ischemic heart disease.
From cardiac ventricle morphogenesis-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate ventricular cardiomyocyte proliferation? | Knockout zebrafish or mouse, EdU staining |
| Does a point mutation in gene Y cause chamber-specific defects? | CRISPR point-mutation knock-in in zebrafish |
| Can overexpression of gene Z rescue ventricular hypoplasia? | Transgenic overexpression in mouse |
| What is the spatial distribution of gene W in the developing ventricle? | Tagged knock-in with fluorescent reporter |
| Does gene V control outflow tract alignment? | Knockout mouse with lineage tracing |
| Can CRISPR library screening identify novel regulators of ventricular morphogenesis? | In vitro cardiomyocyte differentiation from hPSCs with pooled sgRNA library |
How to Study the cardiac ventricle morphogenesis Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Single-cell RNA-seq | Transcriptomes of individual cells | Identify ventricular cell types and states |
| Spatial transcriptomics | Gene expression with spatial context | Map cellular communities in the developing heart |
| Zebrafish video tracking | Cardiac rhythm and function | Automated screening of morphogenesis mutants |
| EdU proliferation assay | DNA synthesis in cardiomyocytes | Assess ventricular wall growth |
| Lineage tracing | Cell fate and contribution | Determine origins of ventricular cells |
| CRISPR knockout | Gene function loss | Test candidate gene necessity |
| CRISPR knock-in | Tagged or mutant protein expression | Study localization and point mutations |
| Overexpression | Gain-of-function | Rescue or drive ventricular growth |
Single-cell and spatial transcriptomics
Single-cell RNA sequencing and spatial transcriptomics have been used to map the cellular communities of the developing human heart, revealing spatially organized cell types in the ventricle. These methods identify gene expression programs that drive ventricular morphogenesis.
Zebrafish cardiac imaging and automated rhythm measurement
Zebrafish are a powerful model for ventricular morphogenesis due to their optical transparency. An OpenCV-based approach enables automated cardiac rhythm measurement from video datasets, facilitating high-throughput functional screening of morphogenesis mutants.
Lineage tracing and genetic fate mapping
Lineage tracing in mouse and zebrafish allows researchers to track the contribution of progenitor cells to the ventricular myocardium. This is essential for understanding how different cell populations assemble the ventricle.
CRISPR-based functional genomics
CRISPR knockout, knock-in, and overexpression models enable causal testing of candidate genes in ventricular morphogenesis. Pooled CRISPR screens can identify novel regulators in cardiomyocyte differentiation systems.
How CRISPR Can Be Used to Study GO:0003208 cardiac ventricle morphogenesis
Knockout
CRISPR knockout of genes such as Hey2, Tbx2, or Mycn in zebrafish or mouse models can reveal their essential roles in ventricular morphogenesis. Knockout models are used to assess loss-of-function phenotypes, including chamber hypoplasia and trabeculation defects.
Point Mutation
CRISPR point mutation knock-in allows the introduction of specific disease-associated mutations into the genome. For example, mutations in Gata4 or Notch1 can be modeled to study their impact on ventricular morphogenesis and injury response.
Knock-in
Knock-in of fluorescent reporters or epitope tags into endogenous loci enables visualization and biochemical analysis of proteins involved in ventricular morphogenesis. This approach has been used to study the spatial organization of cardiac cells.
Overexpression
CRISPR activation (CRISPRa) or transgenic overexpression can drive gain-of-function studies. Overexpression of pro-proliferative genes such as Mycn may enhance ventricular cardiomyocyte proliferation and inform regenerative strategies.
How EDITGENE Supports cardiac ventricle morphogenesis Research
Researchers studying cardiac ventricle morphogenesis-related genes often need to determine whether a candidate gene is causally involved in ventricular development, and what specific mutations do. EDITGENE provides end-to-end CRISPR services to generate precisely engineered cell and animal models for such studies.
Contact EDITGENE today to design your custom CRISPR model for cardiac ventricle morphogenesis research.
Frequently Asked Questions About cardiac ventricle morphogenesis
What is cardiac ventricle morphogenesis GO:0003208?
It is the biological process by which the cardiac ventricle is generated and organized, enabling it to receive blood from the atrium and pump it out of the heart.
What genes are involved in cardiac ventricle morphogenesis?
Key genes include Hey2, Tbx2, Mycn, Gata4, Dll4, and Notch1, which regulate chamber specification, proliferation, and angiogenesis.
How is cardiac ventricle morphogenesis studied?
It is studied using animal models like zebrafish and mouse, single-cell and spatial transcriptomics, and CRISPR-based gene editing.
What diseases are linked to defective cardiac ventricle morphogenesis?
Congenital heart defects such as ventricular septal defects, hypoplastic left heart syndrome, and tetralogy of Fallot.
What is the role of Hey2 in ventricle development?
Hey2 regulates right ventricle development through the Tbx2-Mycn pathway during cardiac morphogenesis.
How does Notch signaling affect ventricular morphogenesis?
DLL4-NOTCH1 signaling controls perinatal angiogenesis from pre-existing coronary vessels, supporting ventricular growth.
Can CRISPR be used to study cardiac ventricle morphogenesis?
Yes, CRISPR knockout, knock-in, and overexpression models enable causal testing of genes in ventricular development.
What is the difference between ventricular and atrial chamber wall formation?
Distinct mechanisms regulate ventricular and atrial wall formation, including differences in cardiomyocyte proliferation and trabeculation.
What is the role of Gata4 in the ventricle?
Gata4 is an injury-responsive transcription factor that shapes the zebrafish cardiac ventricle.
How can I model cardiac ventricle morphogenesis defects in the lab?
Use CRISPR to create knockout or point-mutation models in zebrafish or mouse, combined with imaging and transcriptomics.
Conclusion
Cardiac ventricle morphogenesis (GO:0003208) is a complex developmental process orchestrated by transcription factor networks and signaling pathways. Advances in single-cell and spatial technologies have illuminated the cellular communities that build the ventricle. CRISPR-based models are indispensable for dissecting gene function and modeling congenital heart defects. EDITGENE offers comprehensive services to support this research.
References
- 1. Farah EN et al.. 2024. Spatially organized cellular communities form the developing human heart.. Nature 627(8005):854-864 PMID: 38480880
- 2. Farhan A et al.. 2021. An OpenCV-Based Approach for Automated Cardiac Rhythm Measurement in Zebrafish from Video Datasets.. Biomolecules 11(10) PMID: 34680109
- 3. Seya D et al.. 2021. A role of Hey2 transcription factor for right ventricle development through regulation of Tbx2-Mycn pathway during cardiac morphogenesis.. Dev Growth Differ 63(1):82-92 PMID: 33410138
- 4. Albu M et al.. 2024. Distinct mechanisms regulate ventricular and atrial chamber wall formation.. Nat Commun 15(1):8159 PMID: 39289341
- 5. Gupta V et al.. 2013. An injury-responsive gata4 program shapes the zebrafish cardiac ventricle.. Curr Biol 23(13):1221-7 PMID: 23791730
- 6. Lu P et al.. 2021. Perinatal angiogenesis from pre-existing coronary vessels via DLL4-NOTCH1 signalling.. Nat Cell Biol 23(9):967-977 PMID: 34497373
- 7. Monsanto MM et al.. 2020. Enhancing myocardial repair with CardioClusters.. Nat Commun 11(1):3955 PMID: 32769998
- 8. Rothenberg F et al.. 2003. Sculpting the cardiac outflow tract.. Birth Defects Res C Embryo Today 69(1):38-45 PMID: 12768656
